These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18229418)

  • 21. Prostate screening frequency questioned.
    Health News; 2002 Jul; 8(7):9. PubMed ID: 12132511
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for prostate carcinoma: prostate-specific antigen--friend or foe?
    D'Amico AV
    Cancer; 2005 Mar; 103(5):881-3. PubMed ID: 15637686
    [No Abstract]   [Full Text] [Related]  

  • 24. Canadian MDs begin major push to promote early detection of prostate cancer.
    Spurgeon D
    CMAJ; 1992 Jul; 147(2):220-2. PubMed ID: 1377980
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis.
    Sarrats A; Comet J; Tabarés G; Ramírez M; Aleixandre RN; de Llorens R; Peracaula R
    Prostate; 2010 Jan; 70(1):1-9. PubMed ID: 19670261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rural residence and prostate cancer screening with prostate-specific antigen.
    Stamatiou K; Skolarikos A
    Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological distress and prostate specific antigen levels in men with and without prostate cancer.
    Turner EL; Lane JA; Metcalfe C; Down L; Donovan JL; Hamdy F; Neal D; Vedhara K
    Brain Behav Immun; 2009 Nov; 23(8):1073-8. PubMed ID: 19486654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
    Shao Q; Song J; Zhou ZJ; Du LD
    Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal PSA tests--delays in referral.
    Stapleton AM; Johns RL; Kopsaftis T; Tamblyn DJ; Pinnock CB
    Aust Fam Physician; 2008; 37(1-2):84-8. PubMed ID: 18239761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
    Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
    Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and pathological features of screen vs non-screen-detected prostate cancers: is there a difference?
    Pelzer AE; Colleselli D; Bektic J; Schaefer G; Ongarello S; Schwentner C; Pallwein L; Mitterberger M; Steiner E; Bartsch G; Horninger W
    BJU Int; 2008 Jul; 102(1):24-7. PubMed ID: 18341623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-specific antigen testing for the early detection of prostate cancer.
    Kirby R; Fitzpatrick J
    BJU Int; 2004 Nov; 94(7):966-7. PubMed ID: 15541108
    [No Abstract]   [Full Text] [Related]  

  • 33. Why do I need a prostate exam when my PSA levels are normal?
    Mayo Clin Health Lett; 2006 Apr; 24(4):8. PubMed ID: 16649264
    [No Abstract]   [Full Text] [Related]  

  • 34. Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer.
    Schröder FH; Roobol MJ
    Curr Opin Urol; 2009 May; 19(3):227-31. PubMed ID: 19357513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What to do with an abnormal PSA test.
    Loeb S; Catalona WJ
    Oncologist; 2008 Mar; 13(3):299-305. PubMed ID: 18378540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of prostate cancer].
    Seitz M; Stanislaus P; Stief C
    MMW Fortschr Med; 2008 Jul; 150(28-31):39-41, 43. PubMed ID: 19006891
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in baseline PSA levels in Japanese men from 1988 to 2003.
    Ohi M; Ito K; Yamamoto T; Miyakubo M; Takechi H; Kubota Y; Suzuki K
    Urology; 2008 Jul; 72(1):95-8. PubMed ID: 18455775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.
    Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA
    Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New PSA guidelines for older men.
    Johns Hopkins Med Lett Health After 50; 1998 Sep; 10(7):1-2. PubMed ID: 9715121
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical study of prostate specific antigen failure after radical prostatectomy for prostate cancer: a single center experience].
    Taue R; Takahashi M; Fukawa T; Koizumi T; Nakanishi R; Yamaguchi K; Yamamoto Y; Nakatsuji H; Kishimoto T; Izaki H; Oka N; Fukumori T; Kanayama HO
    Hinyokika Kiyo; 2009 Jan; 55(1):1-4. PubMed ID: 19227203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.